# Trackrad202512456

037228
## Editorial Review — *Rethinking Data Representations in Medical Imaging AI: Deep Learning on Continuous Image Representations Reduces Shortcuts*

### 1. Overall Assessment
This manuscript proposes that classifying in the weight space of Implicit Neural Representations (INRs) passively reduces shortcut learning in medical image analysis without explicit bias labels or harmonisation. The authors demonstrate competitive accuracy between INR classifiers and CNNs on T1-weighted brain MRI and report reduced subgroup performance disparities and improved OOD generalisation in a Parkinson's Disease task. The conceptual premise is coherent and the SimBA-based experimental design is more disciplined than most shortcut-learning studies in this field. However, the entire empirical case rests on a single disease, a single imaging modality, and a single INR architecture. The title promises a general rethinking of medical imaging AI representations; the evidence supports a narrow, provisional observation about morphological shortcut resistance in brain MRI. That mismatch, combined with unresolved cohort confounds and absent ablations, is not correctable by revision.

### 2. Strengths
The SimBA-controlled bias analysis is the paper's most defensible asset, isolating specific bias types on identical subject images in a way real-world data cannot permit. Reproducing the CNN setup from Stanley et al. [27] on identical splits enables a direct and credible comparison. The PCA embedding analysis adds mechanistic depth: demonstrating that morphological bias does not form a separable principal component in the INR classifier — versus 97% decodability in the CNN's third block — provides a plausible mechanistic account of the reduced disparities in Table 1. The four-site OOD experiment is appropriately designed, and the aggregated INR advantage (72.6% vs. 64.9%, McNemar's p=0.0023) constitutes the strongest real-world support for the hypothesis.

### 3. Weaknesses
Every experiment involves T1-weighted brain MRI and Parkinson's Disease. The inductive bias argument is not guaranteed to hold across modalities with different spatial scales and artefact profiles, and publishing this as a general principle is scientifically unjustified. The real-world PD cohort (n=522) carries pronounced site-level sex imbalances — Calgary: 52.38% female HC vs. 32.91% female PD — with no site-stratified subgroup analyses or calibration metrics, leaving the OOD advantage mechanistically unresolved. The INR classifier architecture is never ablated; given that Gielisse and Gemert (CVPR 2025) and Shamsian et al. (arXiv 2024) demonstrate weight-space classifier sensitivity to architecture and augmentation, shortcut resistance cannot be attributed to the weight space in general. Finally, no comparison with computationally lighter debiasing alternatives — Wang et al. (EBioMedicine, 2024) or Boland et al. (MELBA, 2025) — is offered, despite the severe per-scan GPU overhead at inference.

### 4. Editorial Decision
**Reject.** The weaknesses are structural, not correctable by revision within the current scope. Multi-modality, multi-disease evidence and architectural ablations are required to support the claims as written. The work may be appropriate for MICCAI or *Medical Image Analysis* as a proof-of-concept scoped to neuroimaging.

### 5. Suggested Reviewer Expertise
Should this decision be reconsidered, reviewers should hold expertise in: weight-space learning and INR architectures for downstream classification tasks; algorithmic fairness and shortcut learning evaluation in medical image analysis, including familiarity with SimBA and equalized odds frameworks; multi-site neuroimaging harmonisation and OOD generalisation; Parkinson's Disease structural MRI biomarker research; and statistical methods for subgroup disparity analysis under demographic imbalance.


### 6. State-of-the-Art Literature Review
The shortcut learning literature in medical imaging AI has matured rapidly. Stanley et al. (EBioMedicine, 2025) — the direct predecessor — established principled bias encoding analysis within CNNs using SimBA. Glocker et al. (EBioMedicine, 2023) characterised protected attribute encoding in chest X-ray classifiers using multitask learning and model inspection. On mitigation, Wang et al. (EBioMedicine, 2024) showed augmentation-based approaches reduce demographic shortcut exploitation without per-scan overhead, and Boland et al. (MELBA, 2025) demonstrated knowledge distillation from specialist teachers achieves comparable debiasing without bias annotations. Neither is engaged with comparatively. On the INR side, Friedrich et al. (Medfuncta, arXiv 2025) demonstrated modality-agnostic INR representations across medical imaging tasks, directly contextualising this manuscript's novelty claim, which the authors underengage. Gielisse and Gemert (CVPR 2025) and Shamsian et al. (arXiv 2024) document the sensitivity of weight-space classifiers to architecture and augmentation — a finding that makes the absent ablations here a more serious gap than the authors appear to recognise.


### 8. Related Literature — Papers of Similar Scope (Past 3 Years)The following five to six papers share the closest scope with this manuscript — combining shortcut/spurious-correlation analysis, representation learning or data-space intervention, and medical image classification in a multi-site or controlled bias setting.

**1. Stanley et al., "Where, why, and how is bias learned in medical image analysis models?" (EBioMedicine, 2025, ref [27] in the manuscript).** The direct methodological predecessor. Uses SimBA on identical T1-weighted brain MRI data to characterise how CNNs encode morphological and intensity biases in penultimate-layer embeddings via PCA and logistic regression. The present manuscript is, structurally, an extension of this study to weight space; reviewers will hold it to this standard directly.

**2. Gielisse and Gemert, "End-to-End Implicit Neural Representations for Classification" (CVPR, 2025).** Demonstrates that standard two-step INR classification — fit, then classify — substantially underperforms CNN baselines on natural images, and that end-to-end meta-learned SIREN initialisation with a Transformer classifier closes the gap without explicit symmetry equivariance. This directly challenges the architectural assumptions in the present manuscript and is the primary unaddressed competitor.

**3. Ong Ly et al., "Shortcut learning in medical AI hinders generalisation" (npj Digital Medicine, 2024, ref [9] in the manuscript).** Proposes a method for estimating AI model generalisation without external data, specifically targeting shortcut exploitation in multi-site medical imaging settings. Shares the OOD framing and multi-site evaluation design; the present manuscript should have compared its OOD methodology against this approach.

**4. Meng et al., "The limits of fair medical imaging AI in real-world generalisation" (Nature Medicine / arXiv, 2023–2024).** Conducts a systematic investigation of demographic shortcut exploitation in chest X-ray, dermatology, and ophthalmology classifiers across in-distribution and OOD conditions, finding that standard fairness interventions often fail to maintain equity under distribution shift. Directly contextualises the present manuscript's OOD generalisation claims and exposes the absence of comparable multi-modality evidence here.

**5. Wang et al., "Drop the shortcuts: image augmentation improves fairness and decreases AI detection of race and other demographics from medical images" (EBioMedicine, 2024).** Demonstrates that targeted augmentation — a computationally trivial intervention — substantially reduces protected attribute encoding in medical image classifiers. This is the most credible low-cost competing approach to the INR debiasing strategy proposed here and is conspicuously absent from the manuscript's comparative discussion.

**6. Boland, Tsaftaris, and Dahdouh, "Preventing shortcut learning via intermediate layer knowledge distillation from specialist teachers" (MELBA, 2025).** Achieves shortcut resistance comparable to bias-free training data using knowledge distillation, without requiring bias annotations or explicit attribute labels. The parallel to the present manuscript's implicit debiasing claim is direct; that this approach requires neither per-scan GPU fitting nor spatial structure elimination makes it a stronger practical alternative than the manuscript acknowledges.

037302 ---

## Editorial Report: "A Specialized Large Reasoning Model as a Safety Layer for Radiology Reporting Workflows"

### 1. Overall Assessment
This manuscript presents RadioQC-R1, an 8B-parameter large reasoning model trained via three-stage fine-tuning on Qwen3-8B to detect clinically meaningful errors in Chinese radiology reports. The central claim is that domain-specialized reasoning models can function as deployable safety layers across radiology reporting workflows, supported by multicenter benchmarking, human-AI competition and collaboration experiments, and a 100,000-report post-finalization quality control study. While the evaluation scope is ambitious, the work is fundamentally constrained by single-institution data dependency, circular evaluation design, and a post-finalization performance profile (IDR 0.304%, PPV 22.0%) whose clinical utility is contestable.

The two disqualifying concerns are: training, internal validation, and the flagship second-pass quality control experiment all draw exclusively from one Chinese tertiary hospital, making the primary evidence base self-referential; and GPT-4.1 is embedded in both the reward function during training and the evaluation adjudication pipeline, introducing an uncharacterized circularity that undermines the reliability of reported precision and recall figures.

### 2. Strengths
The training corpus is ecologically more valid than most competing systems. The 15,990-report dataset contains 17,589 expert-annotated real-world errors spanning five heterogeneous categories with full clinical context per report, contrasting with the synthetic-error-only corpora used in Sun et al. (*Radiology* 2025) and RadCLARE (Pan et al., *Eur Radiol Exp* 2025).

The three-stage fine-tuning pipeline is technically well-motivated. Applying GRPO with a dual reward function penalizing semantic omissions while enforcing structural standardization is a principled adaptation of DeepSeek-R1-style reinforcement learning to a clinically grounded task.

The human-AI collaboration design is methodologically more rigorous than most prior work. The paired within-reader design with a two-month washout period, independent randomization of case order, and blinding to reference annotations are appropriate safeguards against common confounds.

### 3. Weaknesses
The single-institution data dependency is not mitigated by the external validations. The external cohorts at Institutions 2 and 3 use synthetically generated errors conditioned on Institution 1's error patterns via GPT-5 — meaning the out-of-distribution test is constructed to resemble the training distribution. Generalizability to naturally occurring errors at independent sites remains undemonstrated.

The adjudication circularity is a fundamental methodological flaw. GPT-4.1 is the reward adjudicator during GRPO training; GPT-5 is the evaluation adjudicator. Inter-rater reliability of GPT-5 against the human reviewer across error categories is not reported. Without stratified Cohen's κ, the item-level precision and recall figures are uninterpretable.

The second-pass quality control results do not support the safety layer claim. Only model-flagged cases were adjudicated; the true miss rate across 100,000 reports is unknown. Claiming system-level safety function without estimating sensitivity is not defensible for a clinical deployment argument.

Error 4 (variations in rigor and standardization) shows near-complete model failure — item-level recall of 1.92% overall and strict accuracy of 1.61% — yet appears in aggregate performance figures without qualification and without inter-annotator agreement data to explain the annotation inconsistency.


### 4. Editorial Decision
**Reject.** The three core weaknesses — single-institution circularity, uncharacterized LLM-as-judge bias propagating through both training and evaluation, and an unknown sensitivity in the post-finalization setting — are not addressable through revision. Each requires fundamental redesign. The authors should resubmit following multi-institutional prospective validation with independently annotated ground truth, resolved adjudication methodology, and a full-cohort sensitivity audit. Submission to *Radiology: Artificial Intelligence* or *European Radiology* is more appropriate for the current form.


### 5. Suggested Reviewer Expertise
Reviewers should hold expertise in: reinforcement learning with verifiable rewards applied to structured text generation, specifically GRPO and chain-of-thought fine-tuning of sub-10B parameter models; clinical NLP for radiology report semantics, free-text error taxonomy design, and LLM-as-judge evaluation validity; radiology quality assurance program design with direct experience in peer review, error disclosure, and reporting variability in high-volume tertiary settings; and clinical AI deployment methodology including sensitivity-specificity trade-off analysis for low-prevalence screening applications and regulatory considerations for AI-based clinical decision support.

### 6. State-of-the-Art Literature Review (Past 3 Years)
Automated radiology report error detection has advanced along two parallel tracks: fine-tuned generative LLMs and hybrid rule-LLM systems. Sun et al. (*Radiology* 2025) established that fine-tuning on domain-specific data substantially outperforms zero-shot prompting, using MIMIC-CXR with synthetic errors as the training substrate. Pan et al. (*Eur Radiol Exp* 2025) presented RadCLARE, a BERT-based system trained on 1.4 million Chinese reports with demonstrated post-deployment error rate reduction — a directly competing system this manuscript does not cite. Schmidt et al. (*Radiology: AI* 2024) addressed speech recognition error detection using generative LLMs, defining a narrower but complementary scope. RadReason (arXiv 2025) applied GRPO to radiology report quality evaluation with decomposed sub-scores across six error dimensions, directly paralleling RadioQC-R1's reinforcement learning framing without acknowledgment. Gertz et al. (*Radiology* 2024) evaluated GPT-4 for error detection in radiology reports and documented both the promise and the precision limitations of general-purpose LLMs in this setting. Kaya et al. (*Eur Radiol* 2025) benchmarked GPT-4, GPT-4o, Llama 3-70b, and Mixtral on 120 multi-modality reports with inserted errors, establishing base rates of error-type-specific performance heterogeneity that RadioQC-R1's error-level analysis should be directly compared against.

RadioQC-R1's genuine differentiators are the use of real-world annotated errors at training scale and the 100,000-report second-pass experiment. However, its failure to engage RadCLARE and RadReason, its reliance on synthetic external errors, and the circularity of its adjudication pipeline mean it does not clearly advance the methodological frontier. The most important unresolved question in this domain — performance on naturally occurring errors across demographically and institutionally diverse populations — remains unanswered.

**Directly comparable papers (past 3 years):**

Sun C, Teichman K, Zhou Y, et al. Generative large language models trained for detecting errors in radiology reports. *Radiology*. 2025;315(2):e242575. — Fine-tuned LLMs on MIMIC-CXR synthetic errors; establishes the fine-tuning necessity baseline.

Pan F, Lou J, Guo Y, et al. RadCLARE: an automated clinical language engine for detecting semantic errors in radiology reports. *Eur Radiol Exp*. 2025;9:120. — BERT-based, 1.4M Chinese reports, real-world deployment with pre/post error rate measurement; most direct competitor.

Schmidt RA, Seah JCY, Cao K, et al. Generative large language models for detection of speech recognition errors in radiology reports. *Radiology: AI*. 2024;6(2):e230205. — Narrower error scope (speech recognition), but establishes generative LLM feasibility for error flagging in clinical reports.

Gertz RJ, Dratsch T, Bunck AC, et al. Potential of GPT-4 for detecting errors in radiology reports: implications for reporting accuracy. *Radiology*. 2024;311(1):e232714. — Zero-shot GPT-4 evaluation; defines the general-purpose LLM performance ceiling this paper claims to exceed.

Kaya K, Gietzen C, Hahnfeldt R, et al. Large language models for error detection in radiology reports: a comparative analysis between closed-source and privacy-compliant open-source models. *Eur Radiol*. 2025;35(8):4549–4557. — Multi-model, multi-modality benchmark on inserted errors; establishes error-type performance heterogeneity baselines directly relevant to RadioQC-R1's Error 4 failure.

López-Úbeda P, Martin-Noguerol T, Escartín J, Luna A. Role of NLP in automatic detection of unexpected findings in radiology reports: a comparative study of RoBERTa, CNN, and ChatGPT. *Acad Radiol*. 2024;31(12):4833–4842. — Comparative NLP vs. LLM study on unexpected finding detection; contextualizes the shift from encoder-only to generative architectures that RadioQC-R1 represents.



### 7. Suggested Reviewer Names

**Reinforcement learning / LRM fine-tuning:** Daya Guo (DeepSeek AI, GRPO and reasoning LLMs); Yiliang Zhou (Weill Cornell Medicine, LLM fine-tuning for radiology).

**Clinical NLP / LLM evaluation methodology:** Yifan Peng (Weill Cornell Medicine, radiology NLP and LLM evaluation); Percy Liang (Stanford, HELM and LLM evaluation validity).

**Radiology QA / clinical workflow:** Adam Flanders (Thomas Jefferson University, radiology informatics and reporting quality); Bhavin Jankharia (high-volume radiology practice and AI integration).

**Clinical AI deployment / screening methodology:** Trishan Panch (AI deployment in health systems); Pim Moeskops (clinical AI validation methodology, low-prevalence screening).

NH01821 **EDITORIAL REPORT**
*Nature Communications — Digital Health*

---

**1. Overall Assessment**

This manuscript evaluates nine screening strategies integrating AI-assisted liquid-based cytology (AI-LBC) and high-risk HPV (HR-HPV) testing — standalone, sequential, and co-testing — in a retrospective, population-based cohort of 284,002 women aged 35–64 in Wuhan, China. The central claim is that AI-LBC performs comparably to manual LBC across multiple embedding scenarios, and that Strategy 7 (HR-HPV genotyping with reflex AI-LBC) and Strategy 9 (co-testing) offer favorable sensitivity-to-referral trade-offs.

The cohort scale and systematic strategy-level framing represent genuine advances over prior algorithm-validation studies. Two concerns are decisive. The single-city, proprietary-algorithm design (LANDING LD DNA-ICM II) severely limits generalizability beyond Hubei Province. Residual uncertainty from partial histopathological verification — mitigated but not eliminated by Bayesian imputation — is inadequately reflected in the clinical framing of the authors' program-level recommendations.

---

**2. Strengths**

At 284,002 participants, the cohort substantially exceeds most published AI-LBC evaluation studies and supports stable simultaneous estimation across all nine strategies, with appropriately applied McNemar's tests and Benjamini-Hochberg correction.

The Bayesian multiple imputation framework for verification bias correction — four risk strata, stratum-specific Beta priors anchored to external regional prevalence, Rubin's rules pooling across 20 imputed datasets — is methodologically substantive. Pre/post-correction consistency (Supplementary Table S6) adds credibility without resolving the underlying limitation.

The bubble chart displaying sensitivity versus colposcopy referral burden with Youden's index as bubble size is a practically useful contribution for health program planners navigating multi-dimensional strategy trade-offs.

---

**3. Weaknesses**

Every AI-LBC result was generated by a single frozen algorithm on a single platform not approved outside China. Strategy-level recommendations for settings with "HR-HPV genotyping capacity" imply exportability the evidence cannot support.

No subgroup analyses by ethnicity, education, or residential district are presented, despite Table 1 showing meaningful HPV prevalence variation across these strata. In a cohort of this scale, these stratifications are statistically feasible and clinically necessary by current AI-in-healthcare standards.

No calibration analysis of the Bayesian imputation model is reported. Readers cannot evaluate whether predicted CIN2+ probabilities are well-specified or systematically biased.

---

**4. Editorial Decision**

Recommended for **transfer to *npj Digital Medicine* or *JAMIA***. The cohort is large and methods are reasonable, but the work falls short of the Nature Communications bar: findings are not generalizable beyond the specific platform and program, and policy recommendations exceed what uncosted, single-site evidence can support. Receiving reviewers should adjudicate imputation calibration, feasibility of demographic subgroup analyses, and the appropriateness of recommendations for non-Hubei settings.

---

**5. Suggested Reviewer Expertise**

Reviewers should include specialists in: (1) Bayesian methods for incomplete-data problems in observational screening epidemiology, including verification bias sensitivity analysis; (2) AI-based computational pathology, specifically deep convolutional models for whole-slide cytological image classification; (3) comparative effectiveness research design for diagnostic screening programs, including calibration assessment and decision-curve analysis; (4) cervical cancer screening program implementation in LMICs, including HPV genotyping triage and WHO guideline translation; and (5) health economics and cost-effectiveness modeling for cancer screening in China or comparable middle-income settings.

---

**6. State-of-the-Art Literature Review**

The field has progressed along two largely separate tracks — algorithm accuracy benchmarking and program-level cost-effectiveness modeling — with little work integrating both into real-world strategy comparison at scale. On the algorithm side, a 2024 meta-analysis in *eClinicalMedicine* covering studies through August 2024 confirmed broadly acceptable AI cytology accuracy for CIN2+ detection but flagged single-site design and absence of external validation as endemic weaknesses. The Hologic Genius Digital Diagnostics System received FDA clearance in February 2024, establishing a regulatory benchmark that the LANDING system used here has not met outside China. On the strategy-comparison side, the present paper occupies a genuinely underserved niche, but must be situated against several directly competing publications from the past three years.

**Closely scoped papers (2022–2025):**

Zhu et al. (*Bulletin of the World Health Organization*, 2023) evaluated AI-assisted cytology integrated into a population cervical cancer screening program in China, reporting performance across primary and triage configurations — the most direct structural analog to this paper, yet not engaged substantively in the discussion.

Dun et al. (*Cancer Med*, 2024) pooled individual patient data from nine Chinese population-based cervical screening studies to compare extended HPV genotyping triage strategies at the program level, providing a directly relevant referral-burden benchmark for Strategies 4–7 that the manuscript does not cite or address.

Shen et al. (*Lancet Regional Health – Western Pacific*, 2023) modeled cost-effectiveness of AI-LBC versus manual LBC and HPV-DNA testing across 18 strategy-frequency combinations in China, using modeled rather than observed performance data. The present paper's real-world observed data is its comparative advantage, but the authors do not map their strategy-level findings onto Shen et al.'s economic framework, leaving the policy synthesis incomplete.

Han et al. (*Acta Obstet Gynecol Scand*, 2023) assessed AI-enabled LBC specifically as a triage tool for HPV-positive women in a population-based cross-sectional study — directly relevant to Strategies 6 and 7 here — and reported sensitivity and referral metrics that should serve as an explicit external comparator.

The SMART-HPV modeling study (*Lancet Regional Health – Western Pacific*, January 2025) developed machine-learning risk stratification from full HR-HPV genotyping data in a Chinese population, representing the next-generation competing approach to the rule-based triage strategies evaluated here. The absence of any engagement with AI-driven triage selection — as opposed to AI-driven cytology interpretation — is a notable gap in the manuscript's framing of its own contribution.

Yang et al. (*BMC Cancer*, 2024) clinically evaluated an AI-assisted cytological system across multiple screening strategies in a Chinese high-risk population, reporting sensitivity/specificity breakdowns by strategy type that are directly comparable to Table 2 of the present manuscript and would strengthen or challenge several of the authors' comparative claims.

---

**7. Suggested Reviewer Names**

For Bayesian incomplete-data methods and screening epidemiology: Marek Brabec (Institute of Computer Science, Czech Academy of Sciences), Nora Pashayan (University College London), Hormuzd Katki (National Cancer Institute), Els Goetghebeur (Ghent University).

For AI computational pathology in cytology: Thomas Lampert (University of Strasbourg), Jianzhong Shou (Tsinghua University), Andrew H. Beck (PathAI), Jonhan Ho (University of Pittsburgh Medical Center).

For cervical cancer screening program policy and HPV triage: Marc Arbyn (Belgian Cancer Centre / Sciensano), Silvia de Sanjosé (ISGlobal, Barcelona), Philip Castle (NCI Division of Cancer Prevention), Rengaswamy Sankaranarayanan (formerly IARC).

For health economics of cervical cancer screening: Jane Kim (Harvard T.H. Chan School of Public Health), Karen Canfell (Cancer Council NSW / University of Sydney).

NH03596 **EDITORIAL REPORT — Nature Communications**
*Manuscript: "Asymmetric sociodemographic disparity in evidence-grounded clinical AI"*

---

**1. Overall Assessment**

This Brief Communication applies the Omar et al. four-domain emergency-medicine benchmark to OpenEvidence (OE), a RAG-based clinical LLM used by over 40,000 US physicians daily, asking whether literature grounding eliminates, reproduces, or relocates sociodemographic disparity. OE is equitable across codified decisions but diverges sharply on mental-health screening, with rate ratios of 8.8–9.7 for unhoused cases and asymmetric race-by-gender intersectional effects. A pre-registered inner-layer rationale audit localizes the disparity to reasoning structure rather than the decision itself. The redistribution framing is original and the deployment implications are consequential.

The principal concern is single-system, single-timepoint evaluation of an opaque commercial platform with no physician-derived ground truth, limiting the generalizability of policy-level conclusions about evidence-grounded LLMs as a class.

**2. Strengths**

Direct anchoring to the Omar et al. validated benchmark enables the redistribution claim to be made with precision rather than asserted. The pre-registered, locked 10-axis rubric scored by three independent LLM judges from two vendors, with four concordance criteria required before calling a contrast significant, substantially reduces post-hoc rationalization risk; Cohen κ of 0.74–0.95 is credible. The asymmetric race-inversion in the unhoused pool — White-unhoused exceeding Black-unhoused against real-world epidemiology — is counterintuitive and well-explained by the ecological fallacy mechanism. The agentic deployment framing is concrete and timely.

**3. Weaknesses**

OE's underlying model version and inference parameters are not exposed, preventing replication. The non-uniform prevalence of free-text rationales across pools — transgender cases generating rationales more frequently than unhoused cases — is not ruled out as a selection artifact rather than pure framing bias, which is a material confound for the inner-layer conclusion. The absence of physician-derived ground truth means the mental-health screening rate ratios cannot be distinguished from clinically appropriate elevation. The null finding on codified decisions from 100 cases warrants more cautious framing.

**4. Editorial Decision**

Send for peer review. Reviewers should adjudicate: whether non-uniform rationale prevalence confounds the inner-layer conclusion; whether physician ground truth is necessary to validate the mental-health screening disparity claims; and whether the evidence supports class-level policy conclusions or should be reframed as an OE-specific case study.

---

**5. Suggested Reviewer Expertise**

Reviewers should include expertise in: algorithmic fairness and bias auditing in clinical NLP, specifically controllable perturbation study design and within-case matched analysis; retrieval-augmented generation architectures and their failure modes in medical question answering; emergency medicine clinical decision support with familiarity with mental-health screening and SDOH literature; health equity and intersectionality research at the gender-minority and housing-instability nexus; and pre-registration methodology and inter-rater reliability for LLM-as-judge evaluation paradigms.

---

**6. State-of-the-Art Literature Review**

The parent study (Omar et al., Nat. Med. 2025) is the primary comparator and is appropriately cited. The following five papers share closely overlapping scope and require engagement:

**Levartovsky et al., JAMA Network Open, 2025.** Applied the same demographic-perturbation paradigm to 100 gastroenterology cases across 33 sociodemographic variations using ChatGPT-o1. Findings mirror OE's mental-health screening pattern. This is the most directly competing concurrent publication and is not cited.

**Naous et al., arXiv 2410.07589, 2024.** Demonstrated that RAG undermines LLM fairness even under deliberate mitigation, because retrieved evidence amplifies model confidence on biased responses. Directly relevant to OE's retrieval mechanism and the redistribution hypothesis.

**Poulain, Fayyaz & Beheshti, arXiv 2404.15149, 2024.** Evaluated eight LLMs across three clinical QA datasets using standardized vignettes, providing the most systematic characterization of bias patterns across model architectures in clinical decision support — a missing comparator for OE's RAG-specific profile.

**Omiye et al., npj Digital Medicine, 2023.** Documented that GPT-4 propagates race-based medical misinformation across dermatology and nephrology vignettes, establishing that disparity in clinical LLMs is not limited to emergency medicine and providing a cross-specialty comparator the authors should address.

**Zack et al., NEJM AI, 2024.** Systematically probed GPT-4 for use of race as a clinical variable across 14 medical specialties, finding it perpetuates race-based clinical decision rules in 43% of cases. The mechanism — group-level statistics substituting for individual clinical judgment — is structurally identical to the ecological fallacy the authors document, and should be cited as a prior mechanistic framing.

**Singhal et al. (Med-PaLM 2), Nature, 2023.** Demonstrated that domain-specific grounding improves factual accuracy but does not eliminate demographic performance gaps on MedQA — the clearest precedent for the redistribution hypothesis in a grounded clinical LLM, and conspicuously absent from the manuscript's framing.

---

**7. Suggested Reviewers**

*RAG fairness / clinical NLP bias:* Zhiyong Lu (NLM/NCBI), Irene Li (Yale NLP), Rada Mihalcea (Michigan), Tristan Naous (CMU).

*Health equity / intersectionality:* Ebonie Price-Haywood (Ochsner), Utibe Essien (UCLA), Sharrelle Barber (Drexel).

*Emergency medicine / clinical decision support:* Jesse Pines (George Washington), Lynne Richardson (Mount Sinai).

*Pre-registration / LLM evaluation methodology:* Percy Liang (Stanford HELM), Arvind Narayanan (Princeton).
